| scholarly article | Q13442814 |
| P50 | author | Jenny E Kanter | Q52684544 |
| Karin E. Bornfeldt | Q87887672 | ||
| P2093 | author name string | Chongren Tang | |
| John F Oram | |||
| Renee C Leboeuf | |||
| P2860 | cites work | ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions | Q44406786 |
| Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells | Q46570578 | ||
| Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. | Q46624327 | ||
| Increased ABCA1 activity protects against atherosclerosis | Q57244292 | ||
| Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I | Q57839903 | ||
| Serum fatty acid profiles in type I and type II diabetes: metabolic alterations of fatty acids of the main serum lipids | Q72714413 | ||
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus | Q24314471 | ||
| Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene | Q28206081 | ||
| LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1 | Q28245597 | ||
| Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels | Q28363489 | ||
| Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation | Q30440560 | ||
| Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. | Q30969891 | ||
| Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I | Q33736540 | ||
| Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. | Q34028934 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol | Q34191172 | ||
| HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol | Q34648356 | ||
| Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus | Q34656748 | ||
| Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism | Q35807320 | ||
| Advanced glycation end products and the kidney | Q36256248 | ||
| ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease | Q36267785 | ||
| Glucose and diabetic vascular disease. | Q36379991 | ||
| Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns | Q36431230 | ||
| Lipids and renal disease | Q36432033 | ||
| Scavenger receptors in atherosclerosis: beyond lipid uptake | Q36489900 | ||
| Mechanisms of antimicrobial resistance in bacteria | Q36492671 | ||
| Oxidative stress and macrophage function: a failure to resolve the inflammatory response | Q36764092 | ||
| Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Increased ABCA1 activity protects against atherosclerosis. | Q39738088 | ||
| Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway | Q40166045 | ||
| Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway | Q40381992 | ||
| The Framingham Study: ITS 50-year legacy and future promise | Q40759377 | ||
| Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. | Q40763682 | ||
| Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose | Q42070713 | ||
| Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes | Q42098319 | ||
| High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages | Q43131697 | ||
| ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation | Q43918866 | ||
| Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages | Q43957626 | ||
| Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia | Q44333556 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1719-1728 | |
| P577 | publication date | 2009-11-23 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys | |
| P478 | volume | 51 |
| Q39454322 | Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages |
| Q89754455 | Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats |
| Q41637033 | Angiotensin II induces cholesterol accumulation and injury in podocytes |
| Q36052340 | Anthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in HK-2 cells |
| Q37811885 | Atherosclerosis in chronic kidney disease: the role of macrophages |
| Q35236869 | Cellular cholesterol transport proteins in diabetic nephropathy |
| Q36408997 | Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome. |
| Q37251166 | Cyclodextrin protects podocytes in diabetic kidney disease |
| Q50021708 | Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk |
| Q36658372 | Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation |
| Q37589340 | Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice |
| Q36773876 | Disordered haematopoiesis and athero-thrombosis. |
| Q33963273 | Egg intake during carbohydrate restriction alters peripheral blood mononuclear cell inflammation and cholesterol homeostasis in metabolic syndrome |
| Q50225628 | Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice |
| Q90716283 | Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis |
| Q50511589 | High glucose increases mesangial lipid accumulation via impaired cholesterol transporters. |
| Q91726218 | Inflammasomes, neutrophil extracellular traps, and cholesterol |
| Q35285568 | Lipid biology of the podocyte--new perspectives offer new opportunities |
| Q33740554 | Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy |
| Q34336370 | Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury. |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q58567911 | Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages |
| Q35802292 | Obesity and weight loss result in increased adipose tissue ABCG1 expression in db/db mice |
| Q30249819 | Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. |
| Q51090021 | Peripheral Blood Mononuclear Cell ABCA1 Transcripts and Protein Expression in Acute Myocardial Infarction. |
| Q35740332 | RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes |
| Q34788340 | Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophages |
| Q35341853 | Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism |
| Q37148885 | Systemic and renal lipids in kidney disease development and progression |
| Q33570840 | Tissue cholesterol content alterations in streptozotocin-induced diabetic rats |
| Q35131581 | Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function |
| Q35564129 | Updating experimental models of diabetic cardiomyopathy |
Search more.